Thursday, August 06, 2020 12:56:07 PM
http://www.evbiologics.com/
Evolution of
Biologics Technology
EV Biologics Corporation – a biotechnology company dedicated to the science, study and commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics.
EVs are nano-scale, biological vessels containing bioactive protein and RNA molecules that form an intercellular communications network that governs the structure and function of the body. These natural biological signals directly influence the behavior of the cells that make up the tissues of the body. Certain types of EVs, such as those produced by neonatal stem cells, have demonstrated the innate capacity to suppress inflammation, modulate the immune system, promote cell survival, regenerate tissues, improve vascularity, reduce scarring and suppress cancer.
Enhancement of these intrinsic biological properties through bioengineering will enable EV Biologics to optimize therapeutics for many different disease states and traumatic injuries. The biological profile of circulating exosomes can also indicate pathologic states of the body, allowing the development of diagnostic modalities. The focus of EV Biologics is the development of EV technology for precision biopharmaceuticals, advanced diagnostics and regenerative cosmetics.
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM